Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same

US2022282317A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022282317-A1
Application numberUS-202217730004-A
CountryUS
Kind codeA1
Filing dateApr 26, 2022
Priority dateOct 4, 2017
Publication dateSep 8, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Activity-based probes that can be used to selectively identify and characterize enzymes that are involved in different phases of xenobiotic metabolism in a host and its microbiota population(s) are described. The activity-based probes described specifically label only their target active enzymes involved in xenobiotic metabolism and therefore provide a measurement of true protein functional activity rather than transcript or protein abundance. The activity-based probes also provide multimodal profiling of these active enzymes. Methods for preparing the activity based probes and exemplary methods for their use also are disclosed.

First claim

Opening claim text (preview).

We claim: 1 . A method comprising: exposing a subject or a sample to a probe for a time sufficient to allow the probe to bind to an enzyme involved in xenobiotic metabolism such that a probe-enzyme conjugate is formed; and analyzing the probe-enzyme conjugate using a fluorescent detection technique, a colorimetric detection technique, a mass spectrometry technique, or a combination thereof; wherein the probe comprises a compound of Formula II wherein ERG, if present, is S(O) 2 OH, or an anionic form thereof; P(O)(OH) 2 , or an anionic form thereof; a halogen; or —OPh-CH 2 —ONO 2 ; EBG has a structure satisfying one or more of Formulas IIA EBG -IIJ EBG wherein Y is CH 3 or CF 3 ; Y′ is O, NO 2 , or —N═NR″, wherein R″ is a dye or other reporting moiety; m is an integer selected from 0 to 5; and R′ is selected from aldehyde, ketone, ester, carboxylic acid, acyl, acyl halide, cyano, sulfonate, nitro, nitroso, quaternary amine, CF 3 , alkyl halide, or combinations thereof; Linker a comprises an aliphatic group, a heteroaliphatic group, an aromatic group, an aliphatic-aromatic group, a heteroaliphatic-aromatic group, a heteroaromatic group, an aliphatic-heteroaromatic group, or a heteroaliphatic-heteroaromatic group; each of Linker b and Linker c , if present, independently comprises an aliphatic group, a heteroaliphatic group, an aromatic group, an aliphatic-aromatic group, a heteroaliphatic-aromatic group, a heteroaromatic group, an aliphatic-heteroaromatic group, or a heteroaliphatic-heteroaromatic group; R, if present, is a group comprising a carbamate or a carbonate; each Tag, if present, independently comprises a functional group or molecule capable of generating a detectable signal; each p Tag, which is present if a Tag is not present, independently comprises a clickable functional group; and each of n, m, p, and q independently is 0 or 1. 2 . The method of claim 1 , further comprising exposing the probe-enzyme conjugate to a Tag-containing compound to form a probe-enzyme conjugate comprising a Tag moiety. 3 . The method of claim 1 , further comprising exposing the probe to a light source. 4 . The method of claim 1 , further comprising extracting a subject sample from the subject and analyzing the subject sample using a fluorescent detection technique, a colorimetric detection technique, a mass spectrometry technique, or a combination thereof. 5 . The method of claim 1 , wherein Linker a is a linker group having a structure satisfying one or more of Formulas IIA Linkera -IIH Linkera wherein each n′ independently is an integer ranging from 1 to 50; Z is oxygen or NR′″, wherein R′″ is hydrogen, aliphatic, or aromatic; and Q is carbon, oxygen or NR′″, wherein R′″ is hydrogen, aliphatic, or aromatic. 6 . The method of claim 1 , wherein at least one of the following applies: (a) Linker b is present and comprises a —(CH 2 ) n′ — group, wherein n′ is an integer ranging from 1 to 50; an amide group; or a combination thereof; and/or (b) Linker c is present and has a structure satisfying Formula IIA Linkerc or Formula IIB Linkerc wherein n′ is an integer ranging from 0 to 50; and Z is oxygen or NR′″, wherein R′″ is hydrogen, aliphatic, or aromatic. 7 . The method of claim 1 , wherein R is present and has a structure of one of Formulas IIA R -IID R wherein Z and Z′ independently are oxygen or NR′″, wherein R′″ is hydrogen, aliphatic, or aromatic; and n′ is an integer ranging from 0 to 50. 8 . The method of claim 1 , wherein one or more Tags are present and wherein each Tag independently is a fluorophore, a binding partner of an affinity-based binding pair, a quantum dot, or a dye. 9 . The method of claim 1 , wherein the one or more Tags independently are rhodamine, fluorescein, or biotin. 10 . The method of claim 1 , wherein one or more p Tags are present and wherein each p Tag independently is an azide or an alkyne. 11 . The method of claim 1 , wherein the compound has a structure satisfying Formula IIIA 12 . The method of claim 1 , wherein the ERG is present and is iodo; —OPh-CH 2 —ONO 2 ; 13 . The method of claim 1 , wherein Linker a is an ester group, an —O(CH 2 ) n′ NR′″C(O)(CH 2 ) n′ — group, or a —(CH 2 ) n′ — group, wherein each n′ independently is an integer ranging from 1 to 20 and wherein R′″ is hydrogen, aliphatic, or aromatic. 14 . The method of claim 1 , wherein m is 1 and Linker c is an —NR′″C(O)(CH 2 ) n′ — group or an —NR′″C(O)CH 2 [O(CH 2 ) 2 ] n′ OCH 2 — group, wherein each n′ independently is an integer ranging from 1 to 20 and wherein R′″ is hydrogen, aliphatic, or aromatic. 15 . The method of claim 1 , wherein m is 1 and each Tag, if present, independently is a fluorophore, a binding partner of an affinity-based binding pair, a quantum dot, or a dye; or if a p Tag group is present, then each p Tag independently is an alkyne or an azide. 16 . The method of claim 1 , wherein the probe is selected from: 17 . The method of claim 1 , wherein in Formula (II): ERG is EBG has a structure selected from wherein Y′ is O; m′ is an integer selected from 0 to 5; and each occurrence of R′ is independently selected from aldehyde, ketone, ester, carboxylic acid, acyl, acyl halide, cyano, sulfonate, nitro, nitroso, quaternary amine, CF 3 , alkyl halide, or combinations thereof; Linker a comprises an aliphatic group, a heteroaliphatic group, an aromatic group, an aliphatic-aromatic group, a heteroaliphatic-aromatic group, a heteroaromatic group, an aliphatic-heteroaromatic group, or a heteroaliphatic-heteroaromatic group; each of Linker b and Linker c , if present, independently comprises an aliphatic group, a heteroaliphatic group, an aromatic group, an aliphatic-aromatic group, a heteroaliphatic-aromatic group, a heteroaromatic group, an aliphatic-heteroaromatic group, or a heteroaliphatic-heteroaromat

Assignees

Inventors

Classifications

  • to a carbon atom of a non-condensed six-membered aromatic ring · CPC title

  • Glutathione transferases (2.5.1.18) · CPC title

  • Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism · CPC title

  • substituted in position 7 · CPC title

  • having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022282317A1 cover?
Activity-based probes that can be used to selectively identify and characterize enzymes that are involved in different phases of xenobiotic metabolism in a host and its microbiota population(s) are described. The activity-based probes described specifically label only their target active enzymes involved in xenobiotic metabolism and therefore provide a measurement of true protein functional act…
Who is the assignee on this patent?
Battelle Memorial Institute
What technology area does this patent fall under?
Primary CPC classification C12Q1/6837. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Sep 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).